Home / Health / India First: Teen AVM Treated with New Embolic Agent
India First: Teen AVM Treated with New Embolic Agent
21 Nov
Summary
- A 16-year-old girl received a first-in-India treatment for AVM.
- A minimally invasive technique used a new liquid embolic agent.
- The procedure at Medanta Medicity successfully relieved severe symptoms.
A 16-year-old girl diagnosed with a rare congenital vascular disorder, arteriovenous malformation (AVM), has been successfully treated using a groundbreaking technique in Gurugram. This disorder, characterized by abnormal connections between arteries and veins, caused significant pain and swelling in the patient's right buttock.
The minimally invasive procedure, performed at Medanta Medicity, involved the use of ethylene-vinyl alcohol copolymer (EVOH), a liquid embolic agent typically reserved for complex neurovascular interventions. This marks the first time a peripheral EVOH embolic vial was employed in India for such a condition, offering a precise and controlled method to occlude the abnormal vessels.
The surgery, lasting two hours, effectively treated the AVM and relieved the young patient from symptoms including severe pain, swelling, skin changes, and fever. Doctors highlighted the success as a significant advancement in image-guided interventions for managing high-flow AVMs, especially in young patients where early recognition and treatment are crucial to prevent tissue damage and potentially life-threatening complications.
